{"DataElement":{"publicId":"2593061","version":"1","preferredName":"Residual Neoplasm Breslow Depth Value","preferredDefinition":"The measurement extent downward or inward of remaining tumor expressed using Breslow 's thickness: maximal thickness of a primary cutaneous melanoma measured in tissue sections from the top of the epidermal granular layer, or from the ulcer base (if the tumor is ulcerated), to the bottom of the tumor, with metastatic rates correlating closely with tumor thickness.","longName":"RES_TUM_BRES_VAL","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2503794","version":"1","preferredName":"Residual Neoplasm Breslow Depth","preferredDefinition":"The extent downward or inward of remaining tumor expressed using Breslow 's thickness: maximal thickness of a primary cutaneous melanoma measured in tissue sections from the top of the epidermal granular layer, or from the ulcer base (if the tumor is ulcerated), to the bottom of the tumor, with metastatic rates correlating closely with tumor thickness.","longName":"RES_TUM_BRES_DEPTH","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2503791","version":"1","preferredName":"Residual Neoplasm","preferredDefinition":"Remaining or left behind.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C37895:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Residual","conceptCode":"C37895","definition":"Remaining or left behind.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1A85D824-42F4-4C72-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-08-08","modifiedBy":"ONEDATA","dateModified":"2006-08-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2503792","version":"1","preferredName":"Breslow Depth","preferredDefinition":"Breslow 's thickness. maximal thickness of a primary cutaneous melanoma measured in tissue sections from the top of the epidermal granular layer, or from the ulcer base (if the tumor is ulcerated), to the bottom of the tumor; metastatic rates correlate closely with tumor thickness. (from On-line Medical Dictionary):Depth; extent downward or inward.","longName":"C25734:C25333","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breslow Thickness","conceptCode":"C25734","definition":"The measurement in millimeters of the vertical thickness of primary cutaneous melanoma.  Breslow thickness is measured from the granular layer of the epidermis, or the ulcer base (if ulcerated), to the deepest tumor cells.  It is used in staging of melanoma. (NCI)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Depth","conceptCode":"C25333","definition":"The extent downward or inward; the perpendicular measurement from the surface downward to determine deepness.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1A85D824-4305-4C72-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-08-08","modifiedBy":"ONEDATA","dateModified":"2006-08-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435021","version":"1","preferredName":"Diagnostic or Prognostic Factor","preferredDefinition":"Top level term which includes Biological Markers, Risk Factors, and Prognostic Factors.","longName":"C20047","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741C99A-9B70-231B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1A85D824-4316-4C72-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-08-08","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2593053","version":"1","preferredName":"Breslow Value","preferredDefinition":"A numeric value to represent Breslow 's thickness. maximal thickness of a primary cutaneous melanoma measured in tissue sections from the top of the epidermal granular layer, or from the ulcer base (if the tumor is ulcerated), to the bottom of the tumor; metastatic rates correlate closely with tumor thickness. (from On-line Medical Dictionary)","longName":"BRES_VAL","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"Numeric Alpha DVG","minLength":"1","maxLength":"23","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No source documentation","valueDescription":"No source documentation","ValueMeaning":{"publicId":"2590731","version":"1","preferredName":"No source documentation","longName":"2590731","preferredDefinition":"Data from an original source is not present, accessible or ready for use or service.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Source Data Not Available","conceptCode":"C67329","definition":"Data from an original source is not present, accessible or ready for use or service.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"27F2D64C-2956-74FF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-01-26","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-01-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 01/29/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"285D5833-4CFA-59BD-E044-0003BA3F9857","beginDate":"2007-01-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-31","modifiedBy":"REEVESD","dateModified":"2007-01-31","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2575365","version":"1","preferredName":"Unknown","longName":"2575365","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F372-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"888ED2DC-3794-7A5E-E040-BB89AD4317F2","beginDate":"2010-06-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-08","modifiedBy":"ONEDATA","dateModified":"2010-06-08","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008547","version":"1","preferredName":"Specimen Characteristics","preferredDefinition":"attributes of a patient's laboratory sample, including the source, condition, and fixative.","longName":"SPEC_CHAR","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22908C4-638F-4A74-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2593052","version":"1","preferredName":"Breslow Value","preferredDefinition":"Breslow 's thickness. maximal thickness of a primary cutaneous melanoma measured in tissue sections from the top of the epidermal granular layer, or from the ulcer base (if the tumor is ulcerated), to the bottom of the tumor; metastatic rates correlate closely with tumor thickness. (from On-line Medical Dictionary):A numerical quantity measured or assigned or computed.","longName":"C25734:C25712","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breslow Thickness","conceptCode":"C25734","definition":"The measurement in millimeters of the vertical thickness of primary cutaneous melanoma.  Breslow thickness is measured from the granular layer of the epidermis, or the ulcer base (if ulcerated), to the deepest tumor cells.  It is used in staging of melanoma. (NCI)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"285D5829-8C37-5693-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-01-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-31","modifiedBy":"ONEDATA","dateModified":"2007-01-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"285D5829-8C48-5693-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-01-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-31","modifiedBy":"MAESKEB","dateModified":"2011-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2812205","version":"1","longName":"Arizona Cancer Center","context":"NCIP"},{"publicId":"2812575","version":"1","longName":"AZCC 0210","context":"NCIP"},{"publicId":"2812607","version":"1","longName":"Arizona New CDEs","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Breslow thickness of residual","type":"Preferred Question Text","description":"Breslow thickness of residual (if any)","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"285CD744-FFD7-74A1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-01-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-31","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeDescription":"Curated to support Arizona Cancer Center adoption of C3D","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}